Teva Pharmaceutical Industries Ltd
—- Market cap
- —
- Debt
- +$0.00
- Cash
- −$0.00
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2026 · View financials
Decision snapshot: Teva Pharmaceutical Industries Ltd stock price vs LSCC: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at LSCC's multiple
Needs EPS (TTM), LSCC P/E.
Implied fair value · at Teva Pharmaceutical Industries Ltd's multiple
Needs Teva Pharmaceutical Industries Ltd P/E.
Engine logicTeva Pharmaceutical Industries Ltdvalued onLSCC’smultiple
Metric by metric
Price unavailable
Price unavailable
Where each company leads, and how wide the gap is.
Higher is better
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: Teva Pharmaceutical Industries Ltd Latest annual filing · LSCC FY 2026 (ended Jan 3, 2026). Fiscal years are not aligned.
Trendline
Four fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
TEVA PHARMACEUTICAL INDUSTRIES LTD · implied price per share
Cash flow and years must be positive.
Lattice Semiconductor Corp · implied price per share
Bear
$1.39
Base
$1.63
Bull
$1.88
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Teva Pharmaceutical Industries Ltd · not enough data.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
—
0.20x
Net debt / EBITDA
Leverage against operating earnings
—
0.09x
Cash and equivalents
Liquid reserves on the balance sheet
—
$141.34M
Total debt
Interest-bearing obligations outstanding
—
$145.93M
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
ADVANCED MICRO DEVICES INC
Teva Pharmaceutical Industries Ltd vs AMD
INTEL CORP
Teva Pharmaceutical Industries Ltd vs INTC
NVIDIA CORP
Teva Pharmaceutical Industries Ltd vs NVDA
TEXAS INSTRUMENTS INC
Teva Pharmaceutical Industries Ltd vs TXN
Broadcom Inc.
Teva Pharmaceutical Industries Ltd vs AVGO
SKYWORKS SOLUTIONS, INC.
Teva Pharmaceutical Industries Ltd vs SWKS
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.